Monday, September 14, 2026

Tragic Death from Illegal Filler Injection: What You Need to Know

A Chinese man faces charges for negligent homicide after a woman died from an illegal filler injection in Pyeongtaek.

JTBC Faces Financial Crisis: 5 Central Group Companies Begin Restructuring Hearings Today

Hearings for five companies affiliated with Central Group begin as they seek bankruptcy protection, with JTBC applying for restructuring support.

HLB Therapeutics CEO: New Eye Drop Could Disrupt the Market for Rare Corneal Disease

HLB Therapeutics CEO anticipates RGN-259 could surpass Oxervate within 3 years as a simpler, cost-effective NK treatment.

Tag: SGLT-2

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

JP-2266: The Next-Gen Diabetes Treatment Revolutionizing Blood Sugar Control in Asia

Jeil Pharmaceutical's JP-2266 shows significant blood sugar improvement in phase II trials, with benefits in weight loss and cardiovascular health.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.